Published in J Immunol on May 01, 2007
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov (2008) 4.76
IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J Clin Invest (2009) 3.30
The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in kidney ischemia-reperfusion injury. Kidney Int (2008) 3.30
Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions. Nat Rev Immunol (2013) 2.89
Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans. J Clin Invest (2008) 2.46
Inflammation in acute kidney injury. Nephron Exp Nephrol (2008) 2.32
Compartmentalization of neutrophils in the kidney and lung following acute ischemic kidney injury. Kidney Int (2009) 2.30
Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury. J Am Soc Nephrol (2009) 2.18
Mediators of inflammation in acute kidney injury. Mediators Inflamm (2010) 2.05
Dendritic cells tolerized with adenosine A₂AR agonist attenuate acute kidney injury. J Clin Invest (2012) 2.00
The innate immune response in ischemic acute kidney injury. Clin Immunol (2008) 1.98
KIM-1-mediated phagocytosis reduces acute injury to the kidney. J Clin Invest (2015) 1.80
Ultrasound prevents renal ischemia-reperfusion injury by stimulating the splenic cholinergic anti-inflammatory pathway. J Am Soc Nephrol (2013) 1.76
Macrophages, dendritic cells, and kidney ischemia-reperfusion injury. Semin Nephrol (2010) 1.74
Fresh and cryopreserved, uncultured adipose tissue-derived stem and regenerative cells ameliorate ischemia-reperfusion-induced acute kidney injury. Nephrol Dial Transplant (2010) 1.70
NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFN-gamma and CXCR3 chemokines. Blood (2009) 1.69
Early interleukin 6 production by leukocytes during ischemic acute kidney injury is regulated by TLR4. Kidney Int (2011) 1.63
Adenosine A2A receptors induced on iNKT and NK cells reduce pulmonary inflammation and injury in mice with sickle cell disease. Blood (2010) 1.56
Pathophysiology of acute kidney injury. Compr Physiol (2012) 1.56
Current trends in inflammatory and immunomodulatory mediators in sepsis. J Leukoc Biol (2012) 1.52
Pharmacologic recruitment of regulatory T cells as a therapy for ischemic acute kidney injury. Kidney Int (2011) 1.51
NF-κB is activated in CD4+ iNKT cells by sickle cell disease and mediates rapid induction of adenosine A2A receptors. PLoS One (2013) 1.50
Renal dendritic cells ameliorate nephrotoxic acute kidney injury. J Am Soc Nephrol (2009) 1.39
IL233, A Novel IL-2 and IL-33 Hybrid Cytokine, Ameliorates Renal injury. J Am Soc Nephrol (2017) 1.38
Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review. Naunyn Schmiedebergs Arch Pharmacol (2007) 1.35
Natural killer T cell-derived IL-17 mediates lung ischemia-reperfusion injury. Am J Respir Crit Care Med (2011) 1.35
Regulatory T cells contribute to the protective effect of ischemic preconditioning in the kidney. Kidney Int (2010) 1.31
Activation of sphingosine-1-phosphate 1 receptor in the proximal tubule protects against ischemia-reperfusion injury. J Am Soc Nephrol (2010) 1.31
Interferon-γ production by neutrophils during bacterial pneumonia in mice. Am J Respir Crit Care Med (2010) 1.29
The LTB4-BLT1 axis mediates neutrophil infiltration and secondary injury in experimental spinal cord injury. Am J Pathol (2010) 1.19
Therapeutic translation in acute kidney injury: the epithelial/endothelial axis. J Clin Invest (2014) 1.18
Renal ischemia-reperfusion leads to long term infiltration of activated and effector-memory T lymphocytes. Kidney Int (2008) 1.17
Endogenous IL-10 attenuates cisplatin nephrotoxicity: role of dendritic cells. J Immunol (2010) 1.13
Sulfatide-mediated activation of type II natural killer T cells prevents hepatic ischemic reperfusion injury in mice. Gastroenterology (2010) 1.13
The role of adenosine A2A receptor signaling in bronchiolitis obliterans. Ann Thorac Surg (2009) 1.13
Adenosine signaling via the adenosine 2B receptor is involved in bronchiolitis obliterans development. J Heart Lung Transplant (2010) 1.12
Normal mouse kidneys contain activated and CD3+CD4- CD8- double-negative T lymphocytes with a distinct TCR repertoire. J Leukoc Biol (2008) 1.11
Mice that overexpress human heat shock protein 27 have increased renal injury following ischemia reperfusion. Kidney Int (2008) 1.08
IL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activity. J Clin Invest (2012) 1.07
Chemokine receptor CCR1 regulates inflammatory cell infiltration after renal ischemia-reperfusion injury. J Immunol (2008) 1.06
Netrin-1 regulates the inflammatory response of neutrophils and macrophages, and suppresses ischemic acute kidney injury by inhibiting COX-2-mediated PGE2 production. Kidney Int (2013) 1.04
CD4+ T cell-dependent IFN-γ production by CD8+ effector T cells in Mycobacterium tuberculosis infection. J Immunol (2012) 1.03
Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection. Hum Immunol (2013) 1.02
A mouse diversity panel approach reveals the potential for clinical kidney injury due to DB289 not predicted by classical rodent models. Toxicol Sci (2012) 1.02
Immune mechanisms and novel pharmacological therapies of acute kidney injury. Curr Drug Targets (2009) 1.02
IL-2/anti-IL-2 complex attenuates renal ischemia-reperfusion injury through expansion of regulatory T cells. J Am Soc Nephrol (2013) 1.01
Invariant natural killer T cells and TGF-beta attenuate anti-GBM glomerulonephritis. J Am Soc Nephrol (2009) 1.01
Pathogenesis of acute kidney injury: foundation for clinical practice. Am J Kidney Dis (2011) 0.98
Macrophage-mediated injury and repair after ischemic kidney injury. Pediatr Nephrol (2014) 0.98
Interleukin-18 binding protein transgenic mice are protected against ischemic acute kidney injury. Am J Physiol Renal Physiol (2008) 0.97
Sulfatide-reactive natural killer T cells abrogate ischemia-reperfusion injury. J Am Soc Nephrol (2011) 0.97
IRF-1 promotes inflammation early after ischemic acute kidney injury. J Am Soc Nephrol (2009) 0.96
Enhanced viral immunoinflammatory lesions in mice lacking IL-23 responses. Microbes Infect (2007) 0.96
Amelioration of acute kidney injury in lipopolysaccharide-induced systemic inflammatory response syndrome by an aldose reductase inhibitor, fidarestat. PLoS One (2012) 0.95
Inflammation in AKI: Current Understanding, Key Questions, and Knowledge Gaps. J Am Soc Nephrol (2015) 0.95
The immunomodulatory role of carbon monoxide during transplantation. Med Gas Res (2013) 0.92
Proximal tubule PPARα attenuates renal fibrosis and inflammation caused by unilateral ureteral obstruction. Am J Physiol Renal Physiol (2013) 0.92
Role of leukocytes in the pathogenesis of acute kidney injury. Crit Care (2012) 0.92
Slit2 prevents neutrophil recruitment and renal ischemia-reperfusion injury. J Am Soc Nephrol (2013) 0.91
Dendritic cell sphingosine 1-phosphate receptor-3 regulates Th1-Th2 polarity in kidney ischemia-reperfusion injury. J Immunol (2012) 0.91
Natural IgM anti-leukocyte autoantibodies attenuate excess inflammation mediated by innate and adaptive immune mechanisms involving Th-17. J Immunol (2012) 0.91
CXCR2 knockout mice are protected against DSS-colitis-induced acute kidney injury and inflammation. Am J Physiol Renal Physiol (2013) 0.91
Early exposure to germs modifies kidney damage and inflammation after experimental ischemia-reperfusion injury. Am J Physiol Renal Physiol (2009) 0.91
Tissue-Resident NK Cells Mediate Ischemic Kidney Injury and Are Not Depleted by Anti-Asialo-GM1 Antibody. J Immunol (2015) 0.90
Renoprotective Effects of AVE0991, a Nonpeptide Mas Receptor Agonist, in Experimental Acute Renal Injury. Int J Hypertens (2012) 0.89
TNF-α mediates increased susceptibility to ischemic AKI in diabetes. Am J Physiol Renal Physiol (2013) 0.88
TGF-beta upregulation drives tertiary lymphoid organ formation and kidney dysfunction in calcineurin A-alpha heterozygous mice. Am J Physiol Renal Physiol (2009) 0.88
Tumor Necrosis Factor-α: Life and Death of Hepatocytes During Liver Ischemia/Reperfusion Injury. Ochsner J (2013) 0.87
IFN-γ induction by neutrophil-derived IL-17A homodimer augments pulmonary antibacterial defense. Mucosal Immunol (2015) 0.86
CD4 T-cell suppression by cells from Toxoplasma gondii-infected retinas is mediated by surface protein PD-L1. Infect Immun (2010) 0.86
Netrin-1 regulates colon-kidney cross talk through suppression of IL-6 function in a mouse model of DSS-colitis. Am J Physiol Renal Physiol (2013) 0.86
T cells in organ ischemia reperfusion injury. Curr Opin Organ Transplant (2014) 0.85
Prevention of NKT cell activation accelerates cutaneous wound closure and alters local inflammatory signals. J Surg Res (2010) 0.85
Therapeutic Targets of Human AKI: Harmonizing Human and Animal AKI. J Am Soc Nephrol (2015) 0.85
Inflammation and microvasculopathy in renal ischemia reperfusion injury. J Transplant (2012) 0.85
Reduction in myocardial infarct size at 48 hours after brief intravenous infusion of ATL-146e, a highly selective adenosine A2A receptor agonist. Am J Physiol Heart Circ Physiol (2009) 0.85
A novel role for NKT cells in cutaneous wound repair. J Surg Res (2009) 0.84
Bystander activation of iNKT cells occurs during conventional T-cell alloresponses. Am J Transplant (2011) 0.84
Expanding role of T cells in acute kidney injury. Curr Opin Nephrol Hypertens (2014) 0.84
Acute kidney injury: a conspiracy of Toll-like receptor 4 on endothelia, leukocytes, and tubules. Pediatr Nephrol (2011) 0.83
The alarmin concept applied to human renal transplantation: evidence for a differential implication of HMGB1 and IL-33. PLoS One (2014) 0.82
Neutrophilic granulocytes modulate invariant NKT cell function in mice and humans. J Immunol (2012) 0.82
Guidance cue netrin-1 and the regulation of inflammation in acute and chronic kidney disease. Mediators Inflamm (2014) 0.81
Dendritic cells in acute kidney injury: cues from the microenvironment. Trans Am Clin Climatol Assoc (2012) 0.81
Both PD-1 ligands protect the kidney from ischemia reperfusion injury. J Immunol (2014) 0.81
Mechanisms of interferon-γ production by neutrophils and its function during Streptococcus pneumoniae pneumonia. Am J Respir Cell Mol Biol (2015) 0.80
Inflammatory targets of therapy in sickle cell disease. Transl Res (2015) 0.80
Immunology in the Clinic Review Series; focus on host responses: invariant natural killer T cell activation following transplantation. Clin Exp Immunol (2012) 0.80
Both IL-1β and TNF-α regulate NGAL expression in polymorphonuclear granulocytes of chronic hemodialysis patients. Mediators Inflamm (2011) 0.79
Sphingosine 1-Phosphate Receptor 3-Deficient Dendritic Cells Modulate Splenic Responses to Ischemia-Reperfusion Injury. J Am Soc Nephrol (2015) 0.79
Targeting sphingosine 1 phosphate receptor type 1 receptors in acute kidney injury. Drug Discov Today Dis Mech (2007) 0.79
Advances in the pathogenesis of cardiorenal syndrome type 3. Oxid Med Cell Longev (2015) 0.78
The feasibility of in vivo imaging of infiltrating blood cells for predicting the functional prognosis after spinal cord injury. Sci Rep (2016) 0.78
Double-Negative αβ T Cells Are Early Responders to AKI and Are Found in Human Kidney. J Am Soc Nephrol (2015) 0.78
Mice with an absent stress response are protected against ischemic renal injury. Kidney Int (2014) 0.78
Spontaneous focal activation of invariant natural killer T (iNKT) cells in mouse liver and kidney. BMC Biol (2010) 0.78
AKAP9 regulates activation-induced retention of T lymphocytes at sites of inflammation. Nat Commun (2015) 0.77
Hypoxia-Inducible Factor-2α Limits Natural Killer T Cell Cytotoxicity in Renal Ischemia/Reperfusion Injury. J Am Soc Nephrol (2015) 0.77
Biology of renal recovery: molecules, mechanisms, and pathways. Nephron Clin Pract (2014) 0.77
Innate immunity in donor procurement. Curr Opin Organ Transplant (2013) 0.77
Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol (2005) 4.92
IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J Clin Invest (2009) 3.30
The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in kidney ischemia-reperfusion injury. Kidney Int (2008) 3.30
Synthesis of N-doped graphene by chemical vapor deposition and its electrical properties. Nano Lett (2009) 2.85
Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells. J Clin Oncol (2003) 2.67
Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation. J Exp Med (2006) 2.62
Lymph node-resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentation. J Exp Med (2010) 2.44
Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney. Am J Physiol Renal Physiol (2006) 2.39
Inflammation in acute kidney injury. Nephron Exp Nephrol (2008) 2.32
Compartmentalization of neutrophils in the kidney and lung following acute ischemic kidney injury. Kidney Int (2009) 2.30
Innocuous IFNgamma induced by adjuvant-free antigen restores normoglycemia in NOD mice through inhibition of IL-17 production. J Exp Med (2008) 2.28
Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages. Am J Physiol Renal Physiol (2004) 2.27
Pharmacologic treatment of acute kidney injury: why drugs haven't worked and what is on the horizon. Clin J Am Soc Nephrol (2007) 2.27
Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: the role of CD4+ T cells and IFN-gamma. J Immunol (2006) 2.22
Renal protection from ischemia mediated by A2A adenosine receptors on bone marrow-derived cells. J Clin Invest (2003) 2.22
Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury. J Am Soc Nephrol (2009) 2.18
Relapse or eradication of cancer is predicted by peptide-major histocompatibility complex affinity. Cancer Cell (2013) 2.18
Efflux and compartmentalization of zinc by members of the SLC30 family of solute carriers. Pflugers Arch (2003) 2.17
Deletional self-tolerance to a melanocyte/melanoma antigen derived from tyrosinase is mediated by a radio-resistant cell in peripheral and mesenteric lymph nodes. J Immunol (2007) 2.05
Dendritic cells tolerized with adenosine A₂AR agonist attenuate acute kidney injury. J Clin Invest (2012) 2.00
Tumor masses support naive T cell infiltration, activation, and differentiation into effectors. J Exp Med (2010) 1.97
Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells. Blood (2012) 1.95
Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodology. Clin J Am Soc Nephrol (2012) 1.90
Sphingosine kinase 2 is required for modulation of lymphocyte traffic by FTY720. J Biol Chem (2005) 1.84
Evaluation and initial management of acute kidney injury. Clin J Am Soc Nephrol (2008) 1.83
Ultrasound prevents renal ischemia-reperfusion injury by stimulating the splenic cholinergic anti-inflammatory pathway. J Am Soc Nephrol (2013) 1.76
Macrophages, dendritic cells, and kidney ischemia-reperfusion injury. Semin Nephrol (2010) 1.74
Synthesis and biological evaluation of gamma-aminophosphonates as potent, subtype-selective sphingosine 1-phosphate receptor agonists and antagonists. Bioorg Med Chem (2006) 1.70
Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor control. J Exp Med (2003) 1.68
IL-4 utilizes an alternative receptor to drive apoptosis of Th1 cells and skews neonatal immunity toward Th2. Immunity (2004) 1.61
Dangers within: DAMP responses to damage and cell death in kidney disease. J Am Soc Nephrol (2011) 1.57
Vagus nerve stimulation mediates protection from kidney ischemia-reperfusion injury through α7nAChR+ splenocytes. J Clin Invest (2016) 1.56
Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction. Am J Physiol Gastrointest Liver Physiol (2004) 1.55
Reduced inspiratory muscle endurance following successful weaning from prolonged mechanical ventilation. Chest (2005) 1.53
Adenosine A2A receptor activation attenuates inflammation and injury in diabetic nephropathy. Am J Physiol Renal Physiol (2005) 1.52
Uniform hexagonal graphene flakes and films grown on liquid copper surface. Proc Natl Acad Sci U S A (2012) 1.49
Pillars article: Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 1992. 255: 1261-1263. J Immunol (2007) 1.39
ZnT7, a novel mammalian zinc transporter, accumulates zinc in the Golgi apparatus. J Biol Chem (2002) 1.37
The nexus of acute kidney injury, chronic kidney disease, and World Kidney Day 2009. Clin J Am Soc Nephrol (2009) 1.36
Natural killer T cell-derived IL-17 mediates lung ischemia-reperfusion injury. Am J Respir Crit Care Med (2011) 1.35
Activation of adenosine 2A receptors attenuates allograft rejection and alloantigen recognition. J Immunol (2007) 1.32
Identification of class I MHC-associated phosphopeptides as targets for cancer immunotherapy. Proc Natl Acad Sci U S A (2006) 1.32
Immunity to melanoma antigens: from self-tolerance to immunotherapy. Adv Immunol (2006) 1.31
Regulatory T cells contribute to the protective effect of ischemic preconditioning in the kidney. Kidney Int (2010) 1.31
Activation of sphingosine-1-phosphate 1 receptor in the proximal tubule protects against ischemia-reperfusion injury. J Am Soc Nephrol (2010) 1.31
Blocking the immune response in ischemic acute kidney injury: the role of adenosine 2A agonists. Nat Clin Pract Nephrol (2006) 1.30
A2A adenosine receptors on bone marrow-derived cells protect liver from ischemia-reperfusion injury. J Immunol (2005) 1.30
Specific T regulatory cells display broad suppressive functions against experimental allergic encephalomyelitis upon activation with cognate antigen. J Immunol (2005) 1.26
Structural basis for the presentation of tumor-associated MHC class II-restricted phosphopeptides to CD4+ T cells. J Mol Biol (2010) 1.26
Anti-inflammatory effect of fibrate protects from cisplatin-induced ARF. Am J Physiol Renal Physiol (2005) 1.25
Antigen density presented by dendritic cells in vivo differentially affects the number and avidity of primary, memory, and recall CD8+ T cells. J Immunol (2003) 1.25
Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice. J Immunol (2010) 1.24
Sequential immune escape and shifting of T cell responses in a long-term survivor of melanoma. J Immunol (2005) 1.23
Rapid apoptosis induced by Shiga toxin in HeLa cells. Infect Immun (2003) 1.23
Sequential activation of CD8+ T cells in the draining lymph nodes in response to pulmonary virus infection. J Immunol (2007) 1.23
Intrahepatic IL-10 maintains NKG2A+Ly49- liver NK cells in a functionally hyporesponsive state. J Immunol (2010) 1.22
On the role of dendritic cells in peripheral T cell tolerance and modulation of autoimmunity. J Exp Med (2002) 1.20
Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapy. Proc Natl Acad Sci U S A (2009) 1.19
Tapasin is a facilitator, not an editor, of class I MHC peptide binding. J Immunol (2003) 1.19
The minor histocompatibility antigen HA-3 arises from differential proteasome-mediated cleavage of the lymphoid blast crisis (Lbc) oncoprotein. Blood (2003) 1.18
The PANE1 gene encodes a novel human minor histocompatibility antigen that is selectively expressed in B-lymphoid cells and B-CLL. Blood (2006) 1.17
Analysis of MHC class II antigen processing by quantitation of peptides that constitute nested sets. J Immunol (2002) 1.16
Cardiac surgery as a cause of acute kidney injury: pathogenesis and potential therapies. J Intensive Care Med (2008) 1.15
Distinct role for CD8 T cells toward cutaneous tumors and visceral metastases. J Immunol (2008) 1.15
Technology Insight: biomarker development in acute kidney injury--what can we anticipate? Nat Clin Pract Nephrol (2008) 1.15
Distribution and sources of polycyclic aromatic hydrocarbons from urban to rural soils: a case study in Dalian, China. Chemosphere (2007) 1.14
Design of clinical trials in AKI: a report from an NIDDK workshop. Trials of patients with sepsis and in selected hospital settings. Clin J Am Soc Nephrol (2012) 1.13
MHC class I-associated phosphopeptides are the targets of memory-like immunity in leukemia. Sci Transl Med (2013) 1.13
A marine algicidal actinomycete and its active substance against the harmful algal bloom species Phaeocystis globosa. Appl Microbiol Biotechnol (2012) 1.12
Activation of adenosine 2A receptors preserves structure and function of podocytes. J Am Soc Nephrol (2007) 1.12
Phosphorylation-dependent interaction between antigenic peptides and MHC class I: a molecular basis for the presentation of transformed self. Nat Immunol (2008) 1.11
Implementation of novel biomarkers in the diagnosis, prognosis, and management of acute kidney injury: executive summary from the tenth consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol (2013) 1.11
Semen quality of 1346 healthy men, results from the Chongqing area of southwest China. Hum Reprod (2008) 1.10
Deficient major histocompatibility complex-linked innate murine cytomegalovirus immunity in MA/My.L-H2b mice and viral downregulation of H-2k class I proteins. J Virol (2006) 1.10
Requisite H2k role in NK cell-mediated resistance in acute murine cytomegalovirus-infected MA/My mice. J Immunol (2005) 1.09
Oxygen-aided synthesis of polycrystalline graphene on silicon dioxide substrates. J Am Chem Soc (2011) 1.08
Autocrine adenosine signaling promotes regulatory T cell-mediated renal protection. J Am Soc Nephrol (2012) 1.07
Divergent roles of sphingosine kinases in kidney ischemia-reperfusion injury. Kidney Int (2008) 1.07
Dendritic cell immunization route determines integrin expression and lymphoid and nonlymphoid tissue distribution of CD8 T cells. J Immunol (2007) 1.06